miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin: Erratum

MeSH terms

• Breast Neoplasms* / drug therapy
• Breast Neoplasms* / genetics
• Cell Line, Tumor
• Cell Proliferation
• Drug Resistance, Neoplasm
• Female
• Gene Expression Regulation, Neoplastic
• Humans
• Liver Neoplasms* / genetics
• MicroRNAs* / genetics
• Proteoglycans*
• Vesicular Transport Proteins*